In Brief: Abbott
This article was originally published in The Gray Sheet
Executive Summary
Abbott: Firm responds March 26 to issues raised in an FDA "approvable" letter for its HIV antigen test. The March 22 approvable letter outlined several issues that need to be addressed prior to approval, Abbott says...